Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19

Patients with underlying diseases and coronavirus disease 2019 (COVID-19) are at increased risk of death. Using the recommended anti-COVID-19 drug, chloroquine phosphate (CQ), to treat patients with severe cases and type 2 diabetes (T2D) could potentially cause harm. We aimed to understand the safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiuge, Jing, Xian, Wang, Junqi, Zheng, Yuling, Qiu, Yawei, Ji, Hui, Peng, Lin, Jiang, Shanxiang, Wu, Wenda, Guo, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Book Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023373/
https://www.ncbi.nlm.nih.gov/pubmed/35469826
http://dx.doi.org/10.1016/j.cbi.2022.109954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023373/
https://www.ncbi.nlm.nih.gov/pubmed/35469826
http://dx.doi.org/10.1016/j.cbi.2022.109954

Ejemplares similares